Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2019 / N 2

Лекарственно-индуцированная мегалобластная анемия
О.Д. Остроумова, Е.В. Кравченко

Список литературы

1. Schick P, Nagalla S. Megaloblastic anemia. Medscape (eMedicine). Updated Feb 08, 2019; Available from: https://emedicine.medscape.com/article/204066-overview. Accessed 2019 Oct 30.
2. Stebbins R, Scott J, Herbert V. Drug induced megaloblastic anemias. Seminars in Hematology 1973 Jul;10(3):235-51.
3. Das KC, Das M, Mohanty D, Jadaon MMА, Gupta AА, Marouf RА, Easow SK. Megaloblastosis: from morphos to molecules. Medical Principles and Practice 2005;14(Suppl 1):2-14.
4. Hesdorffer CS, Longo DL. Drug-induced megaloblastic anemia. The New England Journal of Medicine 2015 Oct;373(17):1649-58.
5. Kaferle J, Strzoda СE. Evaluation of macrocytosis. American Family Physician 2009 Feb;79(3):203-8.
6. Богданов А.Н., Мазуров В.И. Мегалобластные анемии. Вестник Санкт-Петербургской медицинской академии постдипломного образования 2010;2(4):82-6.
7. Arshad M, Jaberian S, Pazouki A, Riazi S, Rangraz MA, Mokhber S. Iron deficiency anemia and megaloblastic anemia in obese patients. Romanian Journal of Internal Medicine 2017 Mar;55(1):3-7.
8. Stouten K, Riedl JA, Droogendijk J, Castel R, van Rosmalen J, van Houten RJ, Berendes P, Sonneveld P, Levin MD. Prevalence of potential underlying aetiology of macrocytic anaemia in Dutch general practice. BMC Family Practice 2016 Aug;17(1):113.
9. Tisdale JE, Miller DA. Drug-induced diseases: prevention, detection, and management. Bethesda, MD: American Society of Health-system Pharmacists; 2010: 973-91.
10. Weinblatt ME. Toxicity of low dose methotrexate in rheumatoid arthritis. The Journal of Rheumatology Supplement 1985 Dec;12(Suppl 12):35-9.
11. Evatt ML, Mersereau PW, Bobo JK, Kimmons J, Williams J. Why vitamin B12 deficiency should be on your radar screen. A continuing education update. American Family Physician 2011;83(12):1425-30.
12. Tomkin GH, Hadden DR, Weaver JA, Montgomery DA. Vitamin-B12 status of patients on long-term metformin therapy. British Medical Journal 1971 Jun;2(5763):685-7.
13. Wulffelé MG, Kooy A, Lehert P, Bets D, Ogterop JC, Borger van der Burg B, Donker AJ, Stehouwer CD. Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. Journal of Internal Medicine 2003 Nov;254(5):455-63.
14. Moffatt BA, Ashihara H. Purine and pyrimidine nucleotide synthesis and metabolism. The Arabidopsis Book 2002;1:e0018.
15. Appling DR. Compartmentation of folate-mediated one-carbon metabolism in eukaryotes. FASEB Journal 1991 Sep;5(12):2645-51.
16. Stover PJ, Field MS. Trafficking of intracellular folates. Advances in Nutrition (Bethesda, Md.) 2011 Jul;2(4):325-31.
17. Warnke C, Stüve O, Kieseier BC. Teriflunomide for the treatment of multiple sclerosis. Clinical Neurology and Neurosurgery 2013 Dec;115(Suppl 1):S90-4.
18. He D, Zhang C, Zhao X, Zhang Y, Dai Q, Li Y, Chu L. Teriflunomide for multiple sclerosis. The Cochrane Database of Systematic Reviews 2016 Mar;(3):CD009882.
19. Flippo TS, Holder WD Jr. Neurologic degeneration associated with nitrous oxide anesthesia in patients with vitamin B12 deficiency. The Archives of Surgery (Chicago, Ill.: 1960) 1993 Dec;128(12):1391-5.
20. Yagiela JA. Health hazards and nitrous oxide: a time for reappraisal. Anesthesia Progress 1991 Jan-Feb;38(1):1-11.
21. Chiang TT, Hung CT, Wang WM, Lee JT, Yang FC. Recreational nitrous oxide abuse-induced vitamin B12 deficiency in a patient presenting with hyperpigmentation of the skin. Case Reports in Dermatology 2013 Jun;5(2):186-91.
22. Amess JA, Burman JF, Rees GM, Nancekievill DG, Mollin DL. Megaloblastic haemopoiesis in patients receiving nitrous oxide. The Lancet 1978 Aug;2(8085):339-42.
23. Shipton MJ, Thachil J. Vitamin B12 deficiency – a 21st century perspective. Clinical Medicine (London, England) 2015;15(2):145-50.
24. Healton EB, Savage DG, Brust JC, Garrett TJ, Lindenbaum J. Neurologic aspect of cobalamin deficiency. Medicine (Baltimore) 1991 Jul;70(4):229-45.
25. Moestrup SK. New insights into carrier binding and epithelial uptake of the erythropoietic nutrients cobalamin and folate. Current Opinion in Hematology 2006 May;13(3):119-23.
26. Fedosov SN. Physiological and molecular aspects of cobalamin transport. Subcellular Biochemistry 2012;56:347-67.
27. Prasad AS, Lei KY, Moghissi KS, Stryker JC, Oberleas D. Effect of oral contraceptives on nutrients. III. Vitamins B6, B12, and folic acid. American Journal of Obstetics & Gynecology 1976 Aug;125(8):1063-9.
28. Holzgreve W, Pietrzik K, Koletzko B, Eckmann-Scholz C. Adding folate to the contraceptive pill: a new concept for the prevention of neural tube defects. The Journal of Maternal-Fetal & Neonatal Medicine 2012 Sep;25(9):1529-36.
29. Linnebank M, Moskau S, Semmler A, Widman G, Stoffel-Wagner B, Weller M, Elger CE. Antiepileptic drugs interact with folate and vitamin B12 serum levels. Annals of Neurology 2011 Feb;69(2):352-9.
30. Rollins KD, Lindley C. Pemetrexed: a multitargeted antifolate. Clinical Therapeutics 2005 Sep;27(9):1343-82.
31. Joerger M, Omlin A, Cerny T, Früh M. The role of pemetrexed in advanced non small-cell lung cancer: special focus on pharmacology and mechanism of action. Current Drug Targets 2010 Jan;11(1):37-47.
32. Scagliotti GV, Selvaggi G. New data integrating multitargeted antifolates into treatment of first-line and relapsed non-small-cell lung cancer. Clinical Lung Cancer 2008;9(Suppl 3):S122-8.
33. Hyde JE. Targeting purine and pyrimidine metabolism in human apicomplexan parasites. Current Drug Targets 2007 Jan;8(1):31-47.
34. Moestrup SK, Birn H, Fischer PB, Petersen CM, Verroust PJ, Sim RB, Christensen EI, Nexø E. Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis. Proceedings of the National Academy of Sciences of the USA 1996 Aug;93(16):8612-7.
35. Quadros EV. Advances in the understanding of cobalamin assimilation and metabolism. British Journal of Haematology 2010 Jan;148(2):195-204.
36. Quadros EV, Nakayama Y, Sequeira JM. The protein and the gene encoding the receptor for the cellular uptake of transcobalamin-bound cobalamin. Blood 2009 Jan;113(1):186-92.
37. Liu Q, Li S, Quan H, Li J. Vitamin B12 status in metformin treated patients: systematic review. PLoS One 2014 Jun;9(6):e100379.
38. de Jager J, Kooy A, Lehert P, Wulffelé MG, van der Kolk J, Bets D, Verburg J, Donker AJ, Stehouwer CD. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomized placebo controlled trial. BMJ 2010 May;340:c2181.
39. Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA 2013 Dec;310(22):2435-42.
40. Ruscin JM, Page RL, Valuck RJ. Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor. The Annals of Pharmacotherapy 2002;36(5):812-6.
41. Bellou A, Aimone-Gastin I, De Korwin JD, Bronowicki JP, Moneret-Vautrin A, Nicolas JP, Bigard MA, Guéant JL. Cobalamin deficiency with megaloblastic anaemia in one patient under long-term omeprazole therapy. Journal of Internal Medicine 1996 Sep;240(3):161-4.
42. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B; American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009 Jan;32(1):193-203.
43. Ismail-Beigi F. Clinical practice. Glycemic management of type 2 diabetes mellitus. The New England Journal of Medicine 2012 Apr;366(14):1319-27.
44. Ben Sahra I, Le Marchand-Brustel Y, Tanti JF, Bost F. Metformin in cancer therapy: a new perspective for an old antidiabetic drug? Molecular Cancer Therapeutics 2010 May;9(5):1092-9.
45. Scarpello JH, Howlett HC. Metformin therapy and clinical uses. Diabetes and Vascular Disease Research 2008 Sep;5(3):157-67.
46. Wulffele MG, Kooy A, Lehert P, Bets D, Ogterop JC, Burg B, Donker AJ, Stehouwer CD. Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. Journal of Internal Medicine 2003 Nov;254(5):455-63.
47. Niafar M, Hai F, Porhomayon J, Nader ND. The role of metformin on vitamin B12 deficiency: a meta-analysis review. Internal and Emergency Medicine 2015 Feb;10(1):93-102.
48. Andrès E, Loukili NH, Noel E, Kaltenbach G, Abdelgheni MB, Perrin AE, Noblet-Dick M, Maloisel F, Schlienger JL, Blicklé JF. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ 2004 Aug;171(3):251-9.
49. Ko SH, Ko SH, Ahn YB, Song KH, Han KD, Park YM, Ko SH, Kim HS. Association of vitamin B12 deficiency and metformin use in patients with type 2 diabetes. Journal of Korean Medical Science 2014 Jul;29(7):965-72.
50. Alharbi TJ, Tourkmani AM, Abdelhay O, Alkhashan HI, Al-Asmari AK, Bin Rsheed AM, Abuhaimed SN, Mohammed N, AlRasheed AN, AlHarbi NG. The association of metformin use with vitamin B12 deficiency and peripheral neuropathy in Saudi individuals with type 2 diabetes mellitus. PLoS One 2018 Oct;13(10):e0204420.
51. Kang D, Yun JS, Ko SH, Lim TS, Ahn YB, Park YM, Ko SH. Higher prevalence of metformin-induced vitamin B12 deficiency in sulfonylurea combination compared with insulin combination in patients with type 2 diabetes: a cross-sectional study. PLoS One 2014;9(10):e109878.
52. Bauman WA, Shaw S, Jayatilleke E, Spungen AM, Herbert V. Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin. Diabetes Care 2000 Sep;23(9):1227-31.
53. Fogelman Y, Kitai E, Blumberg G, Golan-Cohen A, Rapoport M, Carmeli E. Vitamin B12 screening in metformin-treated diabetics in primary care: were elderly patients less likely to be tested? Aging Clinical and Experimental Research 2017 Aug;29(2):135-9.
54. Witters LA. The blooming of the French lilac. The Journal of Clinical Investigation 2001;108(8):1105-7.
55. IMS Institute for Healthcare Informatics. Declining medicine use and costs: for better or worse? A review of the use of medicines in the United States in 2013. Available from: https://oversight.house.gov/sites/democrats.oversight.house.gov/files/documents/IMS-Medicine%20use%20and%20shifting%20cost%20of%20healthcare.pdf Accessed 2019 Oct 30.
56. Termanini B, Gibril F, Sutliff VE, Yu F, Venzon DJ, Jensen RT. Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome. The American Journal of Medicine 1998 May;104(5):422-30.
57. Valuck RJ, Ruscin JM. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. Journal of Clinical Epidemiology 2004 Apr;57(4):422-8.
58. Dharmarajan TS, Kanagala MR, Murakonda P, Lebelt AS, Norkus EP. Do acid-lowering agents affect vitamin B12 status in older adults? Journal of the American Medical Directors Association 2008 Mar;9(3):162-7.
59. Marcuard SP, Albernaz L, Khazanie PG. Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12). Annals of Internal Medicine 1994 Feb;120(3):211-5.
60. Abraham NS. Proton pump inhibitors: potential adverse effects. Current Opinion in Gastroenterology 2012;28(6):615-20.
61. Kapadia C. Cobalamin (vitamin B12) deficiency: is it a problem for our aging population and is the problem compounded by drugs that inhibit gastric acid secretion? Journal of Clinical Gastroenterology 2000 Jan;30(1):4-6.
62. Saltzman JR, Kemp JA, Golner BB, Pedrosa MC, Dallal GE, Russell RM. Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption. Journal of the American College of Nutrition 1994 Dec;13(6):584-91.
63. Schenk BE, Festen HP, Kuipers EJ, Klinkenberg-Knol EC, Meuwissen SG. Effect of short- and long-term treatment with omeprazole on the absorption and serum levels of cobalamin. Alimentary Pharmacology & Therapeutics 1996 Aug;10(4):541-5.
64. Jung SB, Nagaraja V, Kapur A, Eslick GD. Association between vitamin B12 deficiency and long-term use of acid lowering agents: a systematic review and meta-analysis. Internal Medicine Journal 2015 Apr;45(4):409-16.
65. Shojania AM, Hornady G, Barnes PH. Oral contraceptives and serum-folate level. The Lancet 1968 Jun;1(7556):1376-7.
66. Cronin M, Schellschmidt I, Dinger J. Rate of pregnancy after using drospirenone and other progestin-containing oral contraceptives. Obstetrics & Gynecology 2009 Sep;114(3):616-22.
67. Colapinto CK, O’Connor DL, Dubois L, Tremblay MS. Prevalence and correlates of folic acid supplement use in Canada. Health Reports 2012 Jun;23(2):39-44.
68. Shere M, Bapat P, Nickel C, Kapur B, Koren G. Association between use of oral contraceptives and folate status: a systematic review and meta-analysis. Journal of Obstetrics & Gynaecology Canada 2015 May;37(5):430-8.
69. Ahmed F, Bamji MS, Iyengar L. Effect of oral contraceptive agents on vitamin nutrition status. The American Journal of Clinical Nutrition 1975 Jun;28(6):606-15.
70. Hettiarachchy NS, Sri Kantha SS, Corea SM. The effect of oral contraceptive therapy and of pregnancy on serum folate levels of rural Sri Lankan women. The British Journal of Nutrition 1983 Nov;50(3):495-501.
71. McLean FW, Heine MW, Held B, Streiff RR. Relationship between the oral contraceptive and folic acid metabolism. Serum folate concentrations. American Journal of Obstetics & Gynecology 1969 Jul;104(5):745-7.
72. Castrén OM, Rossi RR. Effect of oral contraceptives on serum folic acid content. The Journal of Obstetrics & Gynaecology of the British Commonwealth 1970 Jun;77(6):548-50.
73. Paine CJ, Grafton WD, Dickson VL, Eichner ER. Oral contraceptives, serum folate, and hematologic status. JAMA 1975 Feb;231(7):731-3.
74. Sutterlin MW, Bussen SS, Rieger L, Dietl J, Steck T. Serum folate and vitamin B12 levels in women using modern oral contraceptives (OC) containing 20 microg ethinyl estradiol. European Journal of Obstetics, Gynecology, and Reproductive Biology 2003 Mar;107(1):57-61.
75. Lussana F, Zighetti ML, Bucciarelli P, Cugno M, Cattaneo M. Blood levels of homocysteine, folate, vitamin B6 and B12 in women using oral contraceptives compared to non-users. Thrombosis Research 2003;112(1-2):37-41.
76. Green TJ, Houghton LA, Donovan U, Gibson RS, O’Connor DL. Oral contraceptives did not affect biochemical folate indexes and homocysteine concentrations in adolescent females. Journal of American Dietetic Association 1998;98(1):49-55.
77. Riedel B, Bjorke Monsen AL, Ueland PM, Schneede J. Effects of oral contraceptives and hormone replacement therapy on markers of cobalamin status. Clinical Chemistry 2005 Apr;51(4):778-81.
78. Shojania AM, Wylie B. The effect of oral contraceptives on vitamin B12 metabolism. American Journal of Obstetrics & Gynecology 1979 Sep;135(1):129-34.
79. Wertalik LF, Metz EN, LoBuglio AF, Balcerzak SP. Decreased serum B12 levels with oral contraceptive use. JAMA 1972 Sep;221(12):1371-4.
80. Brattstrom L, Israelsson B, Olsson A, Andersson A, Hultberg B. Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma. Scandinavian Journal of Clinical and Laboratory Investigation 1992 Jun;52(4):283-7.
81. Wynn V. Vitamins and oral contraceptive use. The Lancet 1975 Mar;1(7906):561-4.

References

1. Schick P, Nagalla S. Megaloblastic anemia. Medscape (eMedicine). Updated Feb 08, 2019; Available from: https://emedicine.medscape.com/article/204066-overview. Accessed 2019 Oct 30.
2. Stebbins R, Scott J, Herbert V. Drug induced megaloblastic anemias. Seminars in Hematology 1973 Jul;10(3):235-51.
3. Das KC, Das M, Mohanty D, Jadaon MMА, Gupta AА, Marouf RА, Easow SK. Megaloblastosis: from morphos to molecules. Medical Principles and Practice 2005;14(Suppl 1):2-14.
4. Hesdorffer CS, Longo DL. Drug-induced megaloblastic anemia. The New England Journal of Medicine 2015 Oct;373(17):1649-58.
5. Kaferle J, Strzoda СE. Evaluation of macrocytosis. American Family Physician 2009 Feb;79(3):203-8.
6. Bogdanov AN, Mazurov VI. Megaloblastic anemias. Bulletin of St. Petersburg Medical Academy of Postgraduate Studies 2010;2(4):82-6 (In Russian).
7. Arshad M, Jaberian S, Pazouki A, Riazi S, Rangraz MA, Mokhber S. Iron deficiency anemia and megaloblastic anemia in obese patients. Romanian Journal of Internal Medicine 2017 Mar;55(1):3-7.
8. Stouten K, Riedl JA, Droogendijk J, Castel R, van Rosmalen J, van Houten RJ, Berendes P, Sonneveld P, Levin MD. Prevalence of potential underlying aetiology of macrocytic anaemia in Dutch general practice. BMC Family Practice 2016 Aug;17(1):113.
9. Tisdale JE, Miller DA. Drug-induced diseases: prevention, detection, and management. Bethesda, MD: American Society of Health-system Pharmacists; 2010: 973-91.
10. Weinblatt ME. Toxicity of low dose methotrexate in rheumatoid arthritis. The Journal of Rheumatology Supplement 1985 Dec;12(Suppl 12):35-9.
11. Evatt ML, Mersereau PW, Bobo JK, Kimmons J, Williams J. Why vitamin B12 deficiency should be on your radar screen. A continuing education update. American Family Physician 2011;83(12):1425-30.
12. Tomkin GH, Hadden DR, Weaver JA, Montgomery DA. Vitamin-B12 status of patients on long-term metformin therapy. British Medical Journal 1971 Jun;2(5763):685-7.
13. Wulffelé MG, Kooy A, Lehert P, Bets D, Ogterop JC, Borger van der Burg B, Donker AJ, Stehouwer CD. Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. Journal of Internal Medicine 2003 Nov;254(5):455-63.
14. Moffatt BA, Ashihara H. Purine and pyrimidine nucleotide synthesis and metabolism. The Arabidopsis Book 2002;1:e0018.
15. Appling DR. Compartmentation of folate-mediated one-carbon metabolism in eukaryotes. FASEB Journal 1991 Sep;5(12):2645-51.
16. Stover PJ, Field MS. Trafficking of intracellular folates. Advances in Nutrition (Bethesda, Md.) 2011 Jul;2(4):325-31.
17. Warnke C, Stüve O, Kieseier BC. Teriflunomide for the treatment of multiple sclerosis. Clinical Neurology and Neurosurgery 2013 Dec;115(Suppl 1):S90-4.
18. He D, Zhang C, Zhao X, Zhang Y, Dai Q, Li Y, Chu L. Teriflunomide for multiple sclerosis. The Cochrane Database of Systematic Reviews 2016 Mar;(3):CD009882.
19. Flippo TS, Holder WD Jr. Neurologic degeneration associated with nitrous oxide anesthesia in patients with vitamin B12 deficiency. The Archives of Surgery (Chicago, Ill.: 1960) 1993 Dec;128(12):1391-5.
20. Yagiela JA. Health hazards and nitrous oxide: a time for reappraisal. Anesthesia Progress 1991 Jan-Feb;38(1):1-11.
21. Chiang TT, Hung CT, Wang WM, Lee JT, Yang FC. Recreational nitrous oxide abuse-induced vitamin B12 deficiency in a patient presenting with hyperpigmentation of the skin. Case Reports in Dermatology 2013 Jun;5(2):186-91.
22. Amess JA, Burman JF, Rees GM, Nancekievill DG, Mollin DL. Megaloblastic haemopoiesis in patients receiving nitrous oxide. The Lancet 1978 Aug;2(8085):339-42.
23. Shipton MJ, Thachil J. Vitamin B12 deficiency – a 21st century perspective. Clinical Medicine (London, England) 2015;15(2):145-50.
24. Healton EB, Savage DG, Brust JC, Garrett TJ, Lindenbaum J. Neurologic aspect of cobalamin deficiency. Medicine (Baltimore) 1991 Jul;70(4):229-45.
25. Moestrup SK. New insights into carrier binding and epithelial uptake of the erythropoietic nutrients cobalamin and folate. Current Opinion in Hematology 2006 May;13(3):119-23.
26. Fedosov SN. Physiological and molecular aspects of cobalamin transport. Subcellular Biochemistry 2012;56:347-67.
27. Prasad AS, Lei KY, Moghissi KS, Stryker JC, Oberleas D. Effect of oral contraceptives on nutrients. III. Vitamins B6, B12, and folic acid. American Journal of Obstetics & Gynecology 1976 Aug;125(8):1063-9.
28. Holzgreve W, Pietrzik K, Koletzko B, Eckmann-Scholz C. Adding folate to the contraceptive pill: a new concept for the prevention of neural tube defects. The Journal of Maternal-Fetal & Neonatal Medicine 2012 Sep;25(9):1529-36.
29. Linnebank M, Moskau S, Semmler A, Widman G, Stoffel-Wagner B, Weller M, Elger CE. Antiepileptic drugs interact with folate and vitamin B12 serum levels. Annals of Neurology 2011 Feb;69(2):352-9.
30. Rollins KD, Lindley C. Pemetrexed: a multitargeted antifolate. Clinical Therapeutics 2005 Sep;27(9):1343-82.
31. Joerger M, Omlin A, Cerny T, Früh M. The role of pemetrexed in advanced non small-cell lung cancer: special focus on pharmacology and mechanism of action. Current Drug Targets 2010 Jan;11(1):37-47.
32. Scagliotti GV, Selvaggi G. New data integrating multitargeted antifolates into treatment of first-line and relapsed non-small-cell lung cancer. Clinical Lung Cancer 2008;9(Suppl 3):S122-8.
33. Hyde JE. Targeting purine and pyrimidine metabolism in human apicomplexan parasites. Current Drug Targets 2007 Jan;8(1):31-47.
34. Moestrup SK, Birn H, Fischer PB, Petersen CM, Verroust PJ, Sim RB, Christensen EI, Nexø E. Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis. Proceedings of the National Academy of Sciences of the USA 1996 Aug;93(16):8612-7.
35. Quadros EV. Advances in the understanding of cobalamin assimilation and metabolism. British Journal of Haematology 2010 Jan;148(2):195-204.
36. Quadros EV, Nakayama Y, Sequeira JM. The protein and the gene encoding the receptor for the cellular uptake of transcobalamin-bound cobalamin. Blood 2009 Jan;113(1):186-92.
37. Liu Q, Li S, Quan H, Li J. Vitamin B12 status in metformin treated patients: systematic review. PLoS One 2014 Jun;9(6):e100379.
38. de Jager J, Kooy A, Lehert P, Wulffelé MG, van der Kolk J, Bets D, Verburg J, Donker AJ, Stehouwer CD. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomized placebo controlled trial. BMJ 2010 May 20;340:c2181.
39. Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA 2013 Dec;310(22):2435-42.
40. Ruscin JM, Page RL, Valuck RJ. Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor. The Annals of Pharmacotherapy 2002;36(5):812-6.
41. Bellou A, Aimone-Gastin I, De Korwin JD, Bronowicki JP, Moneret-Vautrin A, Nicolas JP, Bigard MA, Guéant JL. Cobalamin deficiency with megaloblastic anaemia in one patient under long-term omeprazole therapy. Journal of Internal Medicine 1996 Sep;240(3):161-4.
42. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B; American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009 Jan;32(1):193-203.
43. Ismail-Beigi F. Clinical practice. Glycemic management of type 2 diabetes mellitus. The New England Journal of Medicine 2012 Apr;366(14):1319-27.
44. Ben Sahra I, Le Marchand-Brustel Y, Tanti JF, Bost F. Metformin in cancer therapy: a new perspective for an old antidiabetic drug? Molecular Cancer Therapeutics 2010 May;9(5):1092-9.
45. Scarpello JH, Howlett HC. Metformin therapy and clinical uses. Diabetes and Vascular Disease Research 2008 Sep;5(3):157-67.
46. Wulffele MG, Kooy A, Lehert P, Bets D, Ogterop JC, Burg B, Donker AJ, Stehouwer CD. Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. Journal of Internal Medicine 2003 Nov;254(5):455-63.
47. Niafar M, Hai F, Porhomayon J, Nader ND. The role of metformin on vitamin B12 deficiency: a meta-analysis review. Internal and Emergency Medicine 2015 Feb;10(1):93-102.
48. Andrès E, Loukili NH, Noel E, Kaltenbach G, Abdelgheni MB, Perrin AE, Noblet-Dick M, Maloisel F, Schlienger JL, Blicklé JF. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ 2004 Aug;171(3):251-9.
49. Ko SH, Ko SH, Ahn YB, Song KH, Han KD, Park YM, Ko SH, Kim HS. Association of vitamin B12 deficiency and metformin use in patients with type 2 diabetes. Journal of Korean Medical Science 2014 Jul;29(7):965-72.
50. Alharbi TJ, Tourkmani AM, Abdelhay O, Alkhashan HI, Al-Asmari AK, Bin Rsheed AM, Abuhaimed SN, Mohammed N, AlRasheed AN, AlHarbi NG. The association of metformin use with vitamin B12 deficiency and peripheral neuropathy in Saudi individuals with type 2 diabetes mellitus. PLoS One 2018 Oct;13(10):e0204420.
51. Kang D, Yun JS, Ko SH, Lim TS, Ahn YB, Park YM, Ko SH. Higher prevalence of metformin-induced vitamin B12 deficiency in sulfonylurea combination compared with insulin combination in patients with type 2 diabetes: a cross-sectional study. PLoS One 2014;9(10):e109878.
52. Bauman WA, Shaw S, Jayatilleke E, Spungen AM, Herbert V. Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin. Diabetes Care 2000 Sep;23(9):1227-31.
53. Fogelman Y, Kitai E, Blumberg G, Golan-Cohen A, Rapoport M, Carmeli E. Vitamin B12 screening in metformin-treated diabetics in primary care: were elderly patients less likely to be tested? Aging Clinical and Experimental Research 2017 Aug;29(2):135-9.
54. Witters LA. The blooming of the French lilac. The Journal of Clinical Investigation 2001;108(8):1105-7.
55. IMS Institute for Healthcare Informatics. Declining medicine use and costs: for better or worse? A review of the use of medicines in the United States in 2013. Available from: https://oversight.house.gov/sites/democrats.oversight.house.gov/files/documents/IMS-Medicine%20use%20and%20shifting%20cost%20of%20healthcare.pdf Accessed 2019 Oct 30.
56. Termanini B, Gibril F, Sutliff VE, Yu F, Venzon DJ, Jensen RT. Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome. The American Journal of Medicine 1998 May;104(5):422-30.
57. Valuck RJ, Ruscin JM. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. Journal of Clinical Epidemiology 2004 Apr;57(4):422-8.
58. Dharmarajan TS, Kanagala MR, Murakonda P, Lebelt AS, Norkus EP. Do acid-lowering agents affect vitamin B12 status in older adults? Journal of the American Medical Directors Association 2008 Mar;9(3):162-7.
59. Marcuard SP, Albernaz L, Khazanie PG. Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12). Annals of Internal Medicine 1994 Feb;120(3):211-5.
60. Abraham NS. Proton pump inhibitors: potential adverse effects. Current Opinion in Gastroenterology 2012;28(6):615-20.
61. Kapadia C. Cobalamin (vitamin B12) deficiency: is it a problem for our aging population and is the problem compounded by drugs that inhibit gastric acid secretion? Journal of Clinical Gastroenterology 2000 Jan;30(1):4-6.
62. Saltzman JR, Kemp JA, Golner BB, Pedrosa MC, Dallal GE, Russell RM. Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption. Journal of the American College of Nutrition 1994 Dec;13(6):584-91.
63. Schenk BE, Festen HP, Kuipers EJ, Klinkenberg-Knol EC, Meuwissen SG. Effect of short- and long-term treatment with omeprazole on the absorption and serum levels of cobalamin. Alimentary Pharmacology & Therapeutics 1996 Aug;10(4):541-5.
64. Jung SB, Nagaraja V, Kapur A, Eslick GD. Association between vitamin B12 deficiency and long-term use of acid lowering agents: a systematic review and meta-analysis. Internal Medicine Journal 2015 Apr;45(4):409-16.
65. Shojania AM, Hornady G, Barnes PH. Oral contraceptives and serum-folate level. The Lancet 1968 Jun;1(7556):1376-7.
66. Cronin M, Schellschmidt I, Dinger J. Rate of pregnancy after using drospirenone and other progestin-containing oral contraceptives. Obstetrics & Gynecology 2009 Sep;114(3):616-22.
67. Colapinto CK, O’Connor DL, Dubois L, Tremblay MS. Prevalence and correlates of folic acid supplement use in Canada. Health Reports 2012 Jun;23(2):39-44.
68. Shere M, Bapat P, Nickel C, Kapur B, Koren G. Association between use of oral contraceptives and folate status: a systematic review and meta-analysis. Journal of Obstetrics & Gynaecology Canada 2015 May;37(5):430-8.
69. Ahmed F, Bamji MS, Iyengar L. Effect of oral contraceptive agents on vitamin nutrition status. The American Journal of Clinical Nutrition 1975 Jun;28(6):606-15.
70. Hettiarachchy NS, Sri Kantha SS, Corea SM. The effect of oral contraceptive therapy and of pregnancy on serum folate levels of rural Sri Lankan women. The British Journal of Nutrition 1983 Nov;50(3):495-501.
71. McLean FW, Heine MW, Held B, Streiff RR. Relationship between the oral contraceptive and folic acid metabolism. Serum folate concentrations. American Journal of Obstetics & Gynecology 1969 Jul;104(5):745-7.
72. Castrén OM, Rossi RR. Effect of oral contraceptives on serum folic acid content. The Journal of Obstetrics & Gynaecology of the British Commonwealth 1970 Jun;77(6):548-50.
73. Paine CJ, Grafton WD, Dickson VL, Eichner ER. Oral contraceptives, serum folate, and hematologic status. JAMA 1975 Feb;231(7):731-3.
74. Sutterlin MW, Bussen SS, Rieger L, Dietl J, Steck T. Serum folate and vitamin B12 levels in women using modern oral contraceptives (OC) containing 20 microg ethinyl estradiol. European Journal of Obstetics, Gynecology, and Reproductive Biology 2003 Mar;107(1):57-61.
75. Lussana F, Zighetti ML, Bucciarelli P, Cugno M, Cattaneo M. Blood levels of homocysteine, folate, vitamin B6 and B12 in women using oral contraceptives compared to non-users. Thrombosis Research 2003;112(1-2):37-41.
76. Green TJ, Houghton LA, Donovan U, Gibson RS, O’Connor DL. Oral contraceptives did not affect biochemical folate indexes and homocysteine concentrations in adolescent females. Journal of American Dietetic Association 1998;98(1):49-55.
77. Riedel B, Bjorke Monsen AL, Ueland PM, Schneede J. Effects of oral contraceptives and hormone replacement therapy on markers of cobalamin status. Clinical Chemistry 2005 Apr;51(4):778-81.
78. Shojania AM, Wylie B. The effect of oral contraceptives on vitamin B12 metabolism. American Journal of Obstetrics & Gynecology 1979 Sep;135(1):129-34.
79. Wertalik LF, Metz EN, LoBuglio AF, Balcerzak SP. Decreased serum B12 levels with oral contraceptive use. JAMA 1972 Sep;221(12):1371-4.
80. Brattstrom L, Israelsson B, Olsson A, Andersson A, Hultberg B. Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma. Scandinavian Journal of Clinical and Laboratory Investigation 1992 Jun;52(4):283-7.
81. Wynn V. Vitamins and oral contraceptive use. The Lancet 1975 Mar;1(7906):561-4.
  

[ Содержание выпуска N 2 | Выпуски журнала | Список журналов ]